Trump suggests Pfizer could win Covid vaccine approval, J&J to come later

WASHINGTON (Reuters) - U.S. President Donald Trump on Monday suggested Pfizer Inc could secure the first U.S. approval of a COVID-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.

Asked which drugmaker could be approved, Trump told Fox News in an interview: "Pfizer's doing really well," adding "Johnson & Johnson ... they'll probably be a little later." He also cited efforts by Moderna Inc and AstraZeneca Plc.

(Reporting by Susan Heavey)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)